Alex Thompson Analyst PerformanceManaging Director Biotechnology at Stifel NicolausAlex Thompson is a stock analyst at Stifel Nicolaus in the medical sector, covering 16 publicly traded companies. Over the past year, Alex Thompson has issued 21 stock ratings, including buy and hold recommendations. While full access to Alex Thompson's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Alex Thompson's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings25 Last 1 YearsBuy Recommendations84.21% 16 Buy RatingsCompanies Covered16 Unique Companies Ratings Distribution19RatingsDistribution of strong buy, buy, hold, and sell ratings by Alex Thompson.RatingPercentageCount Strong Buy0.0%0 ratings Buy84.2%16 ratings Hold15.8%3 ratings Sell0.0%0 ratingsOut of 19 total stock ratings issued by Alex Thompson at Stifel Nicolaus, the majority (84.2%) have been Buy recommendations, followed by 15.8% Hold.Best & Worst CallsBest Call000.0%AVTXMar 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call00.0%CRNXMar 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ100.0% of companies on NASDAQ16 companiesAlex Thompson, an analyst at Stifel Nicolaus, currently covers 16 companies listed on , with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical16 companies100.0%Alex Thompson of Stifel Nicolaus specializes in stock coverage within the Medical sector.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE13 companies81.3%MED - DRUGS3 companies18.8% About Alex ThompsonAlex Thompson, PhD joined Stifel in 2019. Alex is a Managing Director covering stocks in the Biotechnology Sector and is based out of Boston, MA. Alex previously worked as an Associate Vice President with Paul Matteis covering SMID cap biotech at Stifel. Prior to joining Stifel, Alex worked as a consultant at ClearView Healthcare Partners, a consulting firm focused on life sciences strategy. Before ClearView, Alex earned a PhD at Yale University in organic chemistry where he developed new strategies for live-cell super resolution microscopy. While at Yale, Alex published multiple first author papers in high profile journals including Nature Biotechnology. Alex earned a BA in chemistry from Hamilton College.Follow on LinkedIn Alex Thompson's Ratings History at Stifel Nicolaus Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsSYRESpyre Therapeutics3/18/2026Boost Price Target$42.92$92.00Buy$0.0000.00% ROIORKAOruka Therapeutics3/13/2026Boost Price Target$38.47$72.00Buy$0.0000.00% ROIDNTHDianthus Therapeutics3/9/2026Set Price Target$81.81$120.00$0.0000.00% ROIJBIOJade Biosciences3/6/2026Set Price Target$14.06$40.00$0.0000.00% ROIANABAnaptysBio3/5/2026Boost Price Target$60.55$85.00Buy$0.0000.00% ROIASNDAscendis Pharma A/S3/4/2026Set Price Target$241.38$332.00$0.0000.00% ROICLDXCelldex Therapeutics2/26/2026Reiterated Rating$30.82$68.00Buy$0.0000.00% ROIALMSAlumis2/25/2026Initiated Coverage$28.08$44.00Buy$0.0000.00% ROIPALIPalisade Bio2/25/2026Initiated Coverage$1.79$5.00Buy$0.0000.00% ROIASNDAscendis Pharma A/S2/12/2026Set Price Target$217.51$325.00$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. ASNDAscendis Pharma A/S12/11/2025Boost Price Target$201.24$256.00Buy$0.0000.00% ROIARGXargenex12/11/2025Boost Price Target$890.11$1,248.00Buy$0.0000.00% ROIANABAnaptysBio12/11/2025Lower Price Target$44.95$56.00Buy$0.0000.00% ROIKYMRKymera Therapeutics12/8/2025Set Price Target$96.10$114.00$0.0000.00% ROIANABAnaptysBio10/29/2025Boost Price Target$37.20$80.00Buy$0.0000.00% ROIARGXargenex9/18/2025Set Price Target$731.77$882.00$0.0000.00% ROIDNTHDianthus Therapeutics9/12/2025Boost Price Target$36.45$65.00Buy$0.0000.00% ROITVTXTravere Therapeutics9/12/2025Boost Price Target$24.50$25.00Hold$0.0000.00% ROIASNDAscendis Pharma A/S8/8/2025Boost Price Target$183.02$254.00Buy$0.0000.00% ROICGEMCullinan Therapeutics6/11/2025Initiated Coverage$9.00$22.00Buy$0.0000.00% ROIKYMRKymera Therapeutics5/20/2025Initiated Coverage$30.26$55.00Buy$0.0000.00% ROITVTXTravere Therapeutics5/2/2025Boost Price Target$20.61$23.00Hold$00.0000.00% ROITHRDThird Harmonic Bio3/28/2025Reiterated Rating$3.49$5.00Hold$0.0000.00% ROIAVTXAvalo Therapeutics3/25/2025Initiated Coverage$7.63$36.00Buy$00.0000.00% ROICRNXCrinetics Pharmaceuticals3/25/2025Initiated Coverage$35.94$60.00Buy$00.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupCitigroupBarclaysMorgan StanleyWells Fargo & CompanyRoyal Bank Of CanadaJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTruist FinancialTD CowenPiper SandlerRaymond James FinancialStifel Nicolaus Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
